913.3500 16.95 (1.89%)
NSE May 05, 2025 15:31 PM
Volume: 94,252
 

913.35
1.89%
ICICI Securities Limited
Thyrocare Technologies’ (Thyrocare) outperformance in Q4FY25 was driven by surge in volumes (up 15%) and realisation improvement, partially offset by higher ESOP cost.
ICICI Securities Limited increased Buy price target of Thyrocare Technologies Ltd. to 1000.0 on 24 Apr, 2025.
More from Thyrocare Technologies Ltd.
Recommended